Yoshihiro Suzuki-Karasaki

Dr. Yoshihiro Suzuki-Karasaki

Kumamoto University
+1
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
KSKosuke Saito
Kosuke Saito
TATomohiko Asai
Tomohiko Asai
KFKyoko Fujiwara
Kyoko Fujiwara
JSJunki Sahara
Junki Sahara
HKHaruhisa Koguchi
Haruhisa Koguchi
YSYoshihiro Suzuki-Karasaki
Yoshihiro Suzuki-Karasaki
Tumor-selective mitochondrial network collapse induced by atmospheric gas plasma-activated medium

4 April 2021 in Photosynthesis Research
Verified
Journal Article
Closed access
PDF file
ITIchiro TERASHIMA
Ichiro TERASHIMA
MMMitsutoshi Matsuo
Mitsutoshi Matsuo
YSYoshihiro Suzuki-Karasaki
Yoshihiro Suzuki-Karasaki
WYWataru Yamori
Wataru Yamori
MKMasaru Kono
Masaru Kono

Verified
Journal Article
Open access
PDF file
CNChinatsu Nakagawa
Chinatsu Nakagawa
YSYoshihiro Suzuki-Karasaki
Yoshihiro Suzuki-Karasaki
MSMiki Suzuki-Karasaki
Miki Suzuki-Karasaki
TOToyoko Ochiai
Toyoko Ochiai
YSYoshihiro Suzuki-Karasaki
Yoshihiro Suzuki-Karasaki
Allium vegetables such as garlic (Allium sativum L.) are rich in organosulfur compounds that prevent human chronic diseases, including cancer. Of these, diallyl trisulfide (DATS) exhibits anticancer effects against a variety of tumors, including malignant melanoma. Although previous studies have shown that DATS increases intracellular calcium (Ca2+) in different cancer cell types, the role of Ca2+ in the anticancer effect is obscure. In the present study, we investigated the Ca2+ pathways involved in the anti-melanoma effect. We used melittin, the bee venom that can activate a store-operated Ca2+ entry (SOCE) and apoptosis, as a reference. DATS increased apoptosis in human melanoma cell lines in a Ca2+-dependent manner. It also induced mitochondrial Ca2+ (Ca2+mit) overload through intracellular and extracellular Ca2+ fluxes independently of SOCE. Strikingly, acidification augmented Ca2+mit overload, and Ca2+ channel blockers reduced the effect more significantly under acidic pH conditions. On the contrary, acidification mitigated SOCE and Ca2+mit overload caused by melittin. Finally, Ca2+ channel blockers entirely inhibited the anti-melanoma effect of DATS. Our findings suggest that DATS explicitly evokes Ca2+mit overload via a non-SOCE, thereby displaying the anti-melanoma effect.

4 June 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
TATakashi Ando
Takashi Ando
YSYoshihiro Suzuki-Karasaki
Yoshihiro Suzuki-Karasaki
MSMiki Suzuki-Karasaki
Miki Suzuki-Karasaki
JIJiro Ichikawa
Jiro Ichikawa
TOToyoko Ochiai
Toyoko Ochiai
YSYoshihiro Suzuki-Karasaki
Yoshihiro Suzuki-Karasaki
Non-thermal atmospheric pressure plasma (NTAPP)-activated liquids have emerged as new promising anticancer agents because they preferentially injure malignant cells. Here, we report plasma-activated infusion (PAI) as a novel NTAPP-based anti-neoplastic agent. PAI was prepared by irradiating helium NTAP to form a clinically approved infusion fluid. PAI dose-dependently killed malignant melanoma and osteosarcoma cell lines while showing much lower cytotoxic effects on dermal and lung fibroblasts. We found that PAI and salinomycin (Sal), an emerging anticancer stem cell agent, mutually operated as adjuvants. The combined administration of PAI and Sal was much more effective than single-agent application in reducing the growth and lung metastasis of osteosarcoma allografts with minimal adverse effects. Mechanistically, PAI explicitly induced necroptosis and increased the phosphorylation of receptor-interacting protein 1/3 rapidly and transiently. PAI also suppressed the ambient autophagic flux by activating the mammalian target of the rapamycin pathway. PAI increased the phosphorylation of Raptor, Rictor, and p70-S6 kinase, along with decreased LC3-I/II expression. In contrast, Sal promoted autophagy. Moreover, Sal exacerbated the mitochondrial network collapse caused by PAI, resulting in aberrant clustering of fragmented mitochondrial in a tumor-specific manner. Our findings suggest that combined administration of PAI and Sal is a promising approach for treating these apoptosis-resistant cancers.

23 January 2018 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
TTTomohiko Tokunaga
Tomohiko Tokunaga
TATakashi Ando
Takashi Ando
MSMiki Suzuki-Karasaki
Miki Suzuki-Karasaki
TITomohisa Ito
Tomohisa Ito
AOAsuka Onoe-Takahashi
Asuka Onoe-Takahashi
YSYoshihiro Suzuki-Karasaki
Yoshihiro Suzuki-Karasaki
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cold plasma-stimulated medium (PSM) have been shown to exhibit tumor-selective cytotoxicity and have emerged as promising new tools for cancer treatment. However, to date, at least to the best of our knowledge, no data are available as to which substance is more potent in killing cancer cells. Thus, in this study, we systematically compared their abilities to kill human malignant cells from different origins. We found that PSM dose-dependently killed TRAIL-resistant melanoma, osteosarcoma and neuroblastoma cells. Moreover, PSM had little cytotoxicity toward osteoblasts. PSM was more potent than TRAIL in inducing caspase-3/7 activation, mitochondrial network aberration and caspase-independent cell death. We also found that PSM was more potent in inducing plasma membrane depolarization (PMD) and disrupting endoplasmic-mitochondrial Ca2+ homeostasis. Moreover, persistent PMD was caused by different membrane-depolarizing agents; the use of the anti-type II diabetes drug, glibenclamide, alone caused mitochondrial fragmentation and enhanced TRAIL-induced Ca2+ modulation, mitochondrial network abnormalities and caspase-independent cell killing. These results demonstrate that PSM has a therapeutic advantage over TRAIL owing to its greater capacity to evoke caspase-independent cell death via mitochondrial network aberration by disrupting membrane potential and Ca2+ homeostasis. These findings may provide a strong rationale for developing PSM as a novel approach for the treatment of TRAIL-resistant malignant cells.

Verified
Journal Article
Open access
PDF file
YSYoshihiro Suzuki-Karasaki
Yoshihiro Suzuki-Karasaki
TATakashi Ando
Takashi Ando
YOYushi Ochiai
Yushi Ochiai
KKKenta Kawahara
Kenta Kawahara
MSMiki Suzuki-Karasaki
Miki Suzuki-Karasaki
YSYoshihiro Suzuki-Karasaki
Yoshihiro Suzuki-Karasaki
Intractable cancers such as osteosarcoma (OS) and oral cancer (OC) are highly refractory, recurrent, and metastatic once developed, and their prognosis is still disappointing. Tumor-targeted therapy, which eliminates cancers effectively and safely, is the current clinical choice. Since aggressive tumors are substantially resistant to multidisciplinary therapies that target apoptosis, tumor-specific activation of another cell death modality is a promising avenue for meeting this goal. Here, we report that a cold atmospheric air plasma-activated medium (APAM) can kill OS and OC by causing a unique mitochondrial clustering. This event was named monopolar perinuclear mitochondrial clustering (MPMC) based on its characteristic unipolar mitochondrial perinuclear accumulation. The APAM caused apoptotic and nonapoptotic cell death. The APAM increased mitochondrial ROS (mROS) and cell death, and the antioxidants such as N-acetylcysteine (NAC) prevented them. MPMC occurred following mitochondrial fragmentation, which coincided with nuclear damages. MPMC was accompanied by mitochondrial lipid peroxide (mLPO) accumulation and prevented by NAC, Ferrostatin-1, and Nocodazole. In contrast, the APAM induced minimal cell death, mROS generation, mLPO accumulation, and MPMC in fibroblasts. These results suggest that MPMC occurs in a tumor-specific manner via mitochondrial oxidative stress and microtubule-driven mitochondrial motility. MPMC induction might serve as a promising target for exerting tumor-specific cytotoxicity.